BamSEC and AlphaSense Join Forces
Learn More

Niagen Bioscience Inc.

NASDAQ: NAGE    
Share price (8/22/25): $9.98    
Market cap (8/22/25): $796 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 13 pages Sales Agreement
12/34/56
EX-10.2
from 8-K 12 pages Niagen Bioscience, Inc. Employee Stock Purchase Plan
12/34/56
EX-10.1
from 8-K 28 pages Niagen Bioscience, Inc. Amended 2017 Equity Incentive Plan
12/34/56
EX-10.9
from 10-Q 5 pages Niagen Bioscience, Inc. Amended and Restated Incentive Compensation Recoupment Policy
12/34/56
EX-10.8
from 10-Q 2 pages Niagen Bioscience, Inc. Amended and Restated Non-Employee Director Compensation Policy Adopted: November 8, 2016 Amended and Restated: November 16, 2016 Amended and Restated: April 6, 2017 Amended and Restated: June 22, 2018 Amended: March 3, 2025 Effective Date: July 3, 2016
12/34/56
EX-10.7
from 10-Q 7 pages Niagen Bioscience, Inc. 2017 Equity Incentive Plan Restricted Stock Unit Award Agreement
12/34/56
EX-10.6
from 10-Q 8 pages Niagen Bioscience, Inc. 2017 Equity Incentive Plan Option Agreement
12/34/56
EX-10.5
from 10-Q 31 pages Niagen Bioscience, Inc. Amended 2017 Equity Incentive Plan
12/34/56
EX-10.4
from 10-Q 6 pages Seventh Modification to Business Financing Agreement
12/34/56
EX-10.3
from 10-Q 5 pages Second Amendment to Lease
12/34/56
EX-10.58
from 10-K 2 pages Carlos Lopez ** Re: Offer of Employment as Senior Vice President, General Counsel for Chromadex, Inc. Dear Carlos Lopez,
12/34/56
EX-10.38
from 10-K 4 pages Sixth Modification to Business Financing Agreement
12/34/56
EX-10.2
from 8-K 15 pages ChromaDex Corporation Performance Stock Unit Award Grant Notice
12/34/56
EX-10.1
from 8-K 3 pages Amendment to Employment Agreement
12/34/56
EX-10.2
from 10-Q 4 pages Tenth Amendment Manufacturing and Supply Agreement Between W. R. Grace & Co.-Conn. and Chromadex, Inc
12/34/56
EX-10.1
from 8-K 3 pages Material contract
12/34/56
EX-10.1
from 8-K 10 pages June 25, 2024 via Electronic Mail Only Brianna Gerber BRI.GERBER@GMAIL.com
12/34/56
EX-10.60
from 10-K 4 pages Chromadex Corporation Amended and Restated Incentive Compensation Recoupment Policy
12/34/56
EX-10.24
from 10-K 6 pages Recitals
12/34/56
EX-10.2
from 8-K 8 pages Fifth Modification to Business Financing Agreement
12/34/56